| Safety and efficacy of the ChAdOx1 nCoV-19 vaccine AZD1222 against SARS-CoV-2: an interim analysis of four randomized controlled trials in Brazil, South Africa, and the UK | "Covid-19: The E484K mutation and the risks it poses" |
|---|---|
| ChAdOx1nCov-19 provides minimal protection against mild-moderate COVID-19 infection from B | That way when we are infected with , we can mount an effective immune response against it |
Belluz, Julia 23 November 2020.
| The Lancet, 397 10269 : 99-111 | Where is the Oxford-AstraZeneca vaccine made? Mallapaty, Smriti; Callaway, Ewen 2021-03-24 |
|---|---|
| So they took an adenovirus that normally infects chimpanzees, and genetically altered it so it can no longer replicate or cause disease | "A Phase III study to investigate a vaccine against COVID-19" |
Wise, Jacqui 5 February 2021.